Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?

Fersing C, Bouhlel A, Cantelli C, Garrigue P, Lisowski V, Guillet B.

Molecules. 2019 Aug 7;24(16). pii: E2866. doi: 10.3390/molecules24162866. Review.

2.

The HslV Protease from Leishmania major and Its Activation by C-terminal HslU Peptides.

Kebe NM, Samanta K, Singh P, Lai-Kee-Him J, Apicella V, Payrot N, Lauraire N, Legrand B, Lisowski V, Mbang-Benet DE, Pages M, Bastien P, Kajava AV, Bron P, Hernandez JF, Coux O.

Int J Mol Sci. 2019 Feb 26;20(5). pii: E1021. doi: 10.3390/ijms20051021.

3.

Inhibitors of kallikrein-related peptidases: An overview.

Masurier N, Arama DP, El Amri C, Lisowski V.

Med Res Rev. 2018 Mar;38(2):655-683. doi: 10.1002/med.21451. Epub 2017 Jun 13. Review.

PMID:
28609548
4.

Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.

Bellet V, Lichon L, Arama DP, Gallud A, Lisowski V, Maillard LT, Garcia M, Martinez J, Masurier N.

Eur J Med Chem. 2017 Jan 5;125:1225-1234. doi: 10.1016/j.ejmech.2016.11.023. Epub 2016 Nov 11.

PMID:
27871038
5.

Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector.

Vezenkov LL, Sanchez CA, Bellet V, Martin V, Maynadier M, Bettache N, Lisowski V, Martinez J, Garcia M, Amblard M, Hernandez JF.

ChemMedChem. 2016 Feb 4;11(3):302-8. doi: 10.1002/cmdc.201500457. Epub 2015 Dec 7.

PMID:
26639308
6.

Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.

Arama DP, Soualmia F, Lisowski V, Longevial JF, Bosc E, Maillard LT, Martinez J, Masurier N, El Amri C.

Eur J Med Chem. 2015 Mar 26;93:202-13. doi: 10.1016/j.ejmech.2015.02.008. Epub 2015 Feb 7.

PMID:
25682203
7.

Thiazole-based γ-building blocks as reverse-turn mimetic to design a gramicidin S analogue: conformational and biological evaluation.

Legrand B, Mathieu L, Lebrun A, Andriamanarivo S, Lisowski V, Masurier N, Zirah S, Kang YK, Martinez J, Maillard LT.

Chemistry. 2014 May 26;20(22):6713-20. doi: 10.1002/chem.201402190. Epub 2014 Mar 25.

PMID:
24668890
8.

Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.

Gallud A, Vaillant O, Maillard LT, Arama DP, Dubois J, Maynadier M, Lisowski V, Garcia M, Martinez J, Masurier N.

Eur J Med Chem. 2014 Mar 21;75:382-90. doi: 10.1016/j.ejmech.2014.01.044. Epub 2014 Jan 30.

PMID:
24561668
9.

Helical oligomers of thiazole-based γ-amino acids: synthesis and structural studies.

Mathieu L, Legrand B, Deng C, Vezenkov L, Wenger E, Didierjean C, Amblard M, Averlant-Petit MC, Masurier N, Lisowski V, Martinez J, Maillard LT.

Angew Chem Int Ed Engl. 2013 Jun 3;52(23):6006-10. doi: 10.1002/anie.201302106. Epub 2013 Apr 25.

PMID:
23619818
10.

Further characterization of a putative serine protease contributing to the γ-secretase cleavage of β-amyloid precursor protein.

Peuchmaur M, Lacour MA, Sévalle J, Lisowski V, Touati-Jallabe Y, Rodier F, Martinez J, Checler F, Hernandez JF.

Bioorg Med Chem. 2013 Feb 15;21(4):1018-29. doi: 10.1016/j.bmc.2012.11.045. Epub 2012 Dec 5.

PMID:
23294826
11.

Selective C-acylation of 2-aminoimidazo[1,2-a]pyridine: application to the synthesis of imidazopyridine-fused [1,3]diazepinones.

Masurier N, Aruta R, Gaumet V, Denoyelle S, Moreau E, Lisowski V, Martinez J, Maillard LT.

J Org Chem. 2012 Apr 6;77(7):3679-85. doi: 10.1021/jo300364d. Epub 2012 Mar 27.

PMID:
22423645
12.

Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting.

Malcor JD, Payrot N, David M, Faucon A, Abouzid K, Jacquot G, Floquet N, Debarbieux F, Rougon G, Martinez J, Khrestchatisky M, Vlieghe P, Lisowski V.

J Med Chem. 2012 Mar 8;55(5):2227-41. doi: 10.1021/jm2014919. Epub 2012 Feb 14.

PMID:
22257077
13.

Cyclic peptides with a diversely substituted guanidine bridge: solid-phase synthesis and structural analysis.

Touati-Jallabe Y, Chiche L, Hamzé A, Aumelas A, Lisowski V, Berthomieu D, Martinez J, Hernandez JF.

Chemistry. 2011 Feb 25;17(9):2566-70. doi: 10.1002/chem.201003299. Epub 2011 Feb 3. No abstract available.

PMID:
21294201
14.

Synthetic therapeutic peptides: science and market.

Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M.

Drug Discov Today. 2010 Jan;15(1-2):40-56. doi: 10.1016/j.drudis.2009.10.009. Epub 2009 Oct 30. Review.

PMID:
19879957
15.

From thienodiazepinediones to thienopyridinones: flexible synthesis of substituted thieno[3,2-e][1,4]diazepinones and 6-aminothieno[3,2-b]pyridinones.

Brouillette Y, Martinez J, Lisowski V.

J Org Chem. 2009 Jul 17;74(14):4975-81. doi: 10.1021/jo900627a.

PMID:
19480411
16.

Solid-phase synthesis of isocoumarins: a traceless halocyclization approach.

Peuchmaur M, Lisowski V, Gandreuil C, Maillard LT, Martinez J, Hernandez JF.

J Org Chem. 2009 Jun 5;74(11):4158-65. doi: 10.1021/jo900281a.

PMID:
19438216
17.

Thieno[3,2-e]diazepinediones and 3-thienylimidazolidinediones syntheses: regio-controlled ring opening of thiaisatoic anhydride by alpha-amino acids.

Brouillette Y, Lisowski V, Martinez J.

Adv Exp Med Biol. 2009;611:9-10. No abstract available.

PMID:
19400071
18.

Reactivity study of 1H-thieno[3,2-d][1,3]oxazine-2,4-dione toward the synthesis of bicyclic 3,4-dihydro-1H-thieno[3,2-e][1,4]diazepine-2,5-dione analogues.

Brouillette Y, Lisowski V, Fulcrand P, Martinez J.

J Org Chem. 2007 Mar 30;72(7):2662-5. Epub 2007 Feb 27.

PMID:
17323999
19.

Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil.

Omran Z, Cailly T, Lescot E, Santos JS, Agondanou JH, Lisowski V, Fabis F, Godard AM, Stiebing S, Le Flem G, Boulouard M, Dauphin F, Dallemagne P, Rault S.

Eur J Med Chem. 2005 Dec;40(12):1222-45. Epub 2005 Aug 30.

PMID:
16137794
20.

3D-QSAR and docking studies of selective GSK-3beta inhibitors. Comparison with a thieno[2,3-b]pyrrolizinone derivative, a new potential lead for GSK-3beta ligands.

Lescot E, Bureau R, Sopkova-de Oliveira Santos J, Rochais C, Lisowski V, Lancelot JC, Rault S.

J Chem Inf Model. 2005 May-Jun;45(3):708-15.

PMID:
15921460

Supplemental Content

Loading ...
Support Center